BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10

• Press Releases

  Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

  June 1, 2026

   · 

  7 min read
• Press Releases

  Cognition Therapeutics Participating in Upcoming June 2026 Investor Conferences

  June 1, 2026

   · 

  6 min read
• Press Releases

  Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

  June 1, 2026

   · 

  6 min read
• Press Releases

  Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis

  June 1, 2026

   · 

  4 min read
• Press Releases

  NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

  June 1, 2026

   · 

  11 min read
• Press Releases

  Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

  June 1, 2026

   · 

  3 min read
• Press Releases

  Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York 2026

  June 1, 2026

   · 

  5 min read
• Press Releases

  TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

  June 1, 2026

   · 

  15 min read
• Press Releases

  Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

  June 1, 2026

   · 

  10 min read
• Press Releases

  Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

  June 1, 2026

   · 

  10 min read